() chief executive Justin Wheatley tells Proactive London's Andrew Scott 2018 saw strong growth in annualised recurring revenue (ARR) for its flagship Revolution product.
StatPro Revolution's ARR notched up organic year-on-year growth of 17%, up from growth of 13% in 2017.
For the group as a whole, revenue in 2018 rose 11%, or 13% on a constant currency (CC) basis, to £54.84mln from £49.26mln (restated) in 2017.
The UK and Europe were its best-performing regions.
Meet Clinigen Group PLC, MaxCyte, Cello Health PLC, Oncimmune and Silence Therapeutics PLC at our event,
London , 11 July 2019.
Register here »